Product NDC: | 0069-0242 |
Proprietary Name: | Toviaz |
Non Proprietary Name: | fesoterodine fumarate |
Active Ingredient(s): | 4 mg/1 & nbsp; fesoterodine fumarate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0242 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022030 |
Marketing Category: | NDA |
Start Marketing Date: | 20081031 |
Package NDC: | 0069-0242-41 |
Package Description: | 10 BLISTER PACK in 1 CARTON (0069-0242-41) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Code | 0069-0242-41 |
Proprietary Name | Toviaz |
Package Description | 10 BLISTER PACK in 1 CARTON (0069-0242-41) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
Product NDC | 0069-0242 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fesoterodine fumarate |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20081031 |
Marketing Category Name | NDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | FESOTERODINE FUMARATE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes |